MetaCap

Merck Statistics

NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

142.79+0.85 (+0.60%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Merck by the numbers

Merck has a market capitalization of $352.29 billion based on 2.47B shares outstanding. Its trailing P/E ratio is 113.3, above the 8-company peer median of 22.6, and its forward P/E is 15.1. The stock trades 0.1% above its 50-day average and 15.8% above its 200-day average.

Average daily trading volume is 9.82M shares, or about $1.40 billion in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MRK valuation vs. peer median

MRK compared with the median of 8 peer companies
MetricMRKPeer medianDifference
Market cap$352.29B$169.87B+107%
P/E (TTM)113.322.6+402%
Forward P/E15.114.2+6%
Dividend yield2.33%3.26%-29%
Avg. volume9.82M4.14M+137%

Peer median across 8 companies: NVS, AZN, ABBV, ABT, NVO, VRTX, BMY, SNY.

Valuation

Market cap
$352.29B
P/E (TTM)
113.33
Price / sales (latest FY)
5.42

Price and trading

Previous close
141.94
Open
142.03
Day range
141.52 – 144.15
52-week range
82.01 – 156.92
52-week change
+62.98%
Beta
—
Volume
6.35M

Dividends and events

Annual dividend
$3.32
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
352.29B
Pe
113.33
Forward Pe
15.08
Eps
1.26
Dividend Yield
2.38%
Dividend Rate
3.32
Week52 High
156.92
Week52 Low
82.01
Avg Volume
9.82M
Shares Outstanding
2.47B
Ma50
142.68
Ma200
123.28
Earnings Date
Oct 29, 2026
Pct From52w High
-9.00%
Pct From52w Low
74.11%

Related